United States - English - NLM (National Library of Medicine)

morgan gallacher inc. dba custom chemical formulators inc. - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - antiseptic for hand washing to decrease bacteria on the skin.

United States - English - NLM (National Library of Medicine)

maintex - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - antiseptic for hand washing to decrease bacteria on the skin.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - haloperidol, quantity: 2 mg/ml - oral liquid, solution - excipient ingredients: methyl hydroxybenzoate; purified water; propyl hydroxybenzoate; lactic acid - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia

European Union - English - EMA (European Medicines Agency)

sanofi-aventis - rimonabant - obesity - antiobesity preparations, excl. diet products - as an adjunct to diet and exercise for the treatment of obese patients (bmi 30 kg/m2), or overweight patients (bmi 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).

New Zealand - English - Ministry for Primary Industries

upl new zealand limited - paraffin oil - paraffin oil 825 g/litre - insecticide

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - haloperidol, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; (s)-lactic acid - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 0.5mg - tablet - 0.5 mg - active: haloperidol 0.5mg excipient: acacia acid green 50 calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch quinoline yellow - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 1.5mg - tablet - 1.5 mg - active: haloperidol 1.5mg excipient: acacia calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 5mg - tablet - 5 mg - active: haloperidol 5mg excipient: acacia calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch ponceau 4r - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 2 mg/ml; haloperidol 2 mg/ml - oral solution - 2 mg/ml - active: haloperidol 2 mg/ml haloperidol 2 mg/ml excipient: lactic acid methyl hydroxybenzoate propyl hydroxybenzoate purified water - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.